Article

Articles | Volume 4, issue 2

Articles | Volume 4, issue 2

https://doi.org/10.7150/jbji.22118

© Author(s) 2019. This work is distributed under
the Creative Commons Attribution 4.0 License.

https://doi.org/10.7150/jbji.22118

© Author(s) 2019. This work is distributed under
the Creative Commons Attribution 4.0 License.

Articles | Volume 4, issue 2

Brief report

|

02 Mar 2019

Brief report |

| 02 Mar 2019

Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study

C Joseph, O Robineau, M Titecat, S Putman, N Blondiaux, C Loiez, M Valette, JL Schmit, E Beltrand, H Dézeque, S Nguyen, H Migaud, and E Senneville

Cited articles

Osmon DR, Berbari EF, Berendt AR, et al.; Infectious Diseases Society of America. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:1–10.

Senneville E, Joulie D, Legout L. et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis. 2011;53:334–40. [PMC free article]

Titécat M, Senneville E, Wallet F, Dezèque H, Migaud H, Courcol RJ, Loïez C. Microbiologic profile of Staphylococci isolated from osteoarticular infections: evolution over ten years. Surg Infect (Larchmt) 2015;16:77–83.

Domínguez-Herrera J, Docobo-Pérez F, López-Rojas R. et al. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother. 2012;56:613–7. [PMC free article]

Murillo O, Garrigos C, Pachon ME. et al. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009;53:4252–7. [PMC free article]

More articles (5)